MIRA INFORM REPORT

 

Report Date :

25.02.2011

 

IDENTIFICATION DETAILS

 

Name :

ZETA PHARMACEUTICALS LLC

 

 

Formerly Known As :

DWL CONSULTING LLC

 

 

Registered Office :

1 Paragon Drive # 218 Montvale, NJ 07645

 

 

Country :

United States 

 

 

Date of Incorporation :

26.04.2006

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Pharmaceuticals Drugs and Pharmaceutical Products wholesalers

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 100,000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

United States 

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


GEOPOLITICS - UNITED STATES

 

POLITICAL DATA

ECONOMIC DATA

Form of Government: Federal


Economic Risk: Nil

Currency: USD

Branch Situation: Stable

 

 

IDENTIFICATION

 

Ordered as:

Zeta Pharmaceuticals LLc

Address in the order:

One Paragon Drive Suite 218 Montvele NJ 07645

Legal Name:

ZETA PHARMACEUTICALS LLC

Legal Address

1 Paragon Drive # 218 Montvale, NJ 07645

Operative Address

1 Paragon Drive # 218 Montvale, NJ 07645

Telephone:

+1 (201) 930-4934

ID :

3353519

Fax:

+1 (201) 930-4936

Legal Form:

Limited Liability Company

Email:

zeta@zetapharm.com

Registered in:

New York

Website:

www.zetapharm.com 

Date Created:

2001

Manager:

Dieter W. Luelsdorf, President

Date Incorporated:

April 26th, 2006

Staff:

10

Stock:

NA

 

 

Value:

NA

Activity:

Pharmaceuticals Drugs and Pharmaceutical Products wholesalers.

 

 

BANKS

 

Name of the Bank

TD Bank

 

 

BUSINESS

 

HISTORY

 

The company was founded in 2001. 

It was formerly known as DWL CONSULTING LLC, and changed its name to ZETA PHARMACEUTICALS LLC in MAY 11, 2009.

PRINCIPAL ACTIVITY

 

This company wholesales Pharmaceuticals Drugs and Pharmaceutical Products.

The company imports bulk active and inactive ingredients for the US market.

It emphazises in OTC and prescription pharmaceutical markets.

The company offers a broad and diversified range of APIs to human and veterinary dosage manufacturers.

Products/Services description:

 

ACTIVE OTC INGREDIENTS:

Acetaminophen (Various mesh sizes)

Acetaminophen, DC grade

Acetaminophen, 8 hr. CR

Aspirin (Various mesh sizes)

Aspirin DC-90

Bismuth Subsalicylate

 (Regular & Suspension Grade)

Caffeine Anhydrous (Crystalline & Powder)

Calcium Polycarbophil

Dextromethorphan HBr

Diphenhydramine HCl

Docusate Sodium, 85%

Hydrocortisone Base and HCl

Hyoscyamine Sulfate

Icthammol

Methscopolamine Nitrate

Methenamine

Pamabrom

Polyethylene Glycols

Among Others

 

 

 

 

Generics:

Allopurinol

Alprazolam

Bicalutamide

Carisoprodol

Clindamycin HCl

Clindamycin Phosphate

Clonazepam

Chlordiazepoxide HCl

Diazepam

Divalproex, Sodium

Donepezil HCl

Fluorouracil

Galantamine HBr

Glimepiride

Guaifenesin

Isosorbide Mononitrate

Lisinopril

Loratidine

Lorazepam

Losartan Potassium

Lovastatin

 Metformin HCl

Methylphenobarbital

Metoprolol Succinate

Modafinil

Niacin

Oxybutynin HCl

Among others

 

Generic Pipeline:

Adapalene

Alfuzosin HCl

Allopurinol, Sodium

Bisoprolol Fumerate

Benztropine Mesylate

Capecitabine

Caspofungin

Clavulanate, Potassium

Cyclobenzaprine HCl

Desonide

Desvenlafaxine

Epirubicin HCl

Eplenerone

Fluticasone Propionate

Gemcitabine HCl

Hydroxyzine HCl

Ifosfamide

Ipratropium Bromide

Irinotecan HCl

Isoflurane

Isradipine

Levalbuterol HCl

Levalbuterol Tartrate

Mesna

Metaxalone

Among others

 

 

 

 

Sales are:

 

Wholesale

Brands:

 

Harman Finochem 

Nantong Jinghua Pharmaceutical Company

Stearinerie Dubois Company

Suppliers:

 

Harman Finochem 

Stearinerie Dubois Company (France)

Nantong Jinghua Pharmaceutical Company

Operations area:

 

National, International

The company imports from Asia, Europe and Latin America.

The company export to Mexico, Puerto Rico and Canada

PAYMENTS

 

regular

LOCATION

Headquarters

 

The company is headquartered at One Paragon Drive Suite 218 Montvele NJ 07645.

 




Shareholders - Manager - Related Companies

 

Listed at the stock exchange:

 

NO

Shareholders Parent Company(ies):

 

This company is privately held. Dieter W. Luelsdorf is one of the main shareholder.

Management:

 

Dieter W. Luelsdorf, President

Susan Navarro, Accountant

Irene Chourrot, Customer Service



Financials - COMMERCIAL TRENDS AND FORECAST

 

As a private company‚ the subject does not publish any financial statements.

We have contacted Susan who refused to provide us any financial data on grounds of confidentiality without knowing the name of the inquiring party.

However our financial sources could provide us with the following data.

 

Those figures are estimates provided by confidential banking and financial institutions working with the company.

 

Currency

DATE

USD

2009

Turnover

7,340,000

Net Income

367,000

Net worth

600,000

Liabilities

931,000

The cash flow is

Normal

 

Legal Fillings

 There is one UCC files listed with the Secretary of State of New York.

 

There are no legal filings listed with the District Court.

 

THE COMPANY IS NOT LISTED ON THE OFAC LIST.*

 

 

For information:

 

* The Specially Designated Nationals (SDN) List is a publication of OFAC which lists individuals and organizations with whom United States citizens and permanent residents are prohibited from doing business.

 

** The Uniform Commercial Code (UCC) is one of a number of uniform acts that have been promulgated in conjunction with efforts to harmonize the law of sales and other commercial transactions in all 50 states within the United States of America. 

 

The UCC deals primarily with transactions involving personal property (movable property), not real property (immovable property).

 

It allows a creditor to notify other creditors about a debtor's assets used as collateral for a secured transaction by filing a public notice (financing statement) with a particular filing office.

 

The Uniform Commercial Code Bureau files and maintains on financial obligations (including IRS liens) incurred by individuals (in business as a sole proprietor), business entities and corporations.



Rating

 

Local credit bureau gave a Low credit rate.

 

The company is in Good Standing. This means that all local and federal taxes were paid on due date.

 Final Opinion

 

This is a small sized company, with 10 employees and 10 years of experience.

There were no legal filings found against the company or its legal representatives.

 

We have contacted the company but they refused to provide us with any financial information without knowing the name of the inquiring party.

 

The company gave a good profitability for the year 2009.

 

A credit line may be considered for USD 100,000

 

 

SUMMARY

 


FINANCIAL SUMMARY


DEBT COLLECTIONS AND PAYMENTS

Profitability

CORRECT

Public Records

NO

 

Indebtedness

N.A.

Payments

REGULAR

 

Cash

N.A.

 

 

 

 




APPENDIX

 

Person Interviewed

 

Susan Novarro

Position

 

Accountant

Comments

 

She refused to provide us with any information about the company without knowing the exact name of the inquiring party, due to confidentiality reasons.

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.37

UK Pound

1

Rs.73.54

Euro

1

Rs.62.39

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.